What is the value of regional cerebral saturation in post-cardiac arrest patients? A prospective observational study. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Genbrugge, Cornelia; Eertmans, Ward; Meex, Ingrid; Van Kerrebroeck, Margaretha; Daems, Noami; Creemers, An; Jans, Frank; Boer, Willem; Dens, Jo; De Deyne, Cathy
• Is Part Of: Critical care. Volume 20:Issue 1(2016)
• Page Start: 1
• Page End: 9
• Publication Date: 2016-12
• Subjects: Cerebral saturation -- Post-cardiac arrest -- Neurological outcome -- Neuromonitoring -- Targeted temperature management; Critical care medicine -- Periodicals; 616.02805
• DOI: 10.1186/s13054-016-1509-9
• Languages: English
• ISSNs: 1364-8535

Abstract

Abstract Background The aim of this study was to elucidate the possible role of cerebral saturation monitoring in the post-cardiac arrest setting. Methods Cerebral tissue saturation (SctO2 ) was measured in 107 successfully resuscitated out-of-hospital cardiac arrest patients for 48 hours between 2011 and 2015. All patients were treated with targeted temperature management, 24 hours at 33 °C and rewarming at 0.3 °C per hour. A threshold analysis was performed as well as a linear mixed models analysis for continuous SctO2 data to compare the relation between SctO2 and favorable (cerebral performance category (CPC) 1–2) and unfavorable outcome (CPC 3–4–5) at 180 days post-cardiac arrest in OHCA patients. Results Of the 107 patients, 50 (47 %) had a favorable neurological outcome at 180 days post-cardiac arrest. Mean SctO2 over 48 hours was 68 % ± 4 in patients with a favorable outcome compared to 66 % ± 5 for patients with an unfavorable outcome (p = 0.035). No reliable SctO2 threshold was able to predict favorable neurological outcome. A significant different course of SctO2 was observed, represented by a logarithmic and linear course of SctO2 in patients with favorable outcome and unfavorable outcome, respectively (p < 0.001). During the rewarming phase, significant higher SctO2 values were observed in patients with a favorable neurological outcome (p = 0.046). Conclusions This study represents the largest post-resuscitation cohort evaluated using NIRS technology, including a sizeable cohort of balloon-assisted patients. Although a significant difference was observed in the overall course of SctO2 between OHCA patients with a favorable and unfavorable outcome, the margin was too small to likely represent functional outcome differentiation based on SctO2 alone. As such, these results given such methodology as performed in this study suggest that NIRS is insufficient by itself to serve in outcome prognostication, but there may remain benefit when incorporated into a multi-neuromonitoring bedside assessment algorithm.